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Introduction {#sec1}
============

During development, the lung undergoes branching morphogenesis, where a series of stereotyped epithelial bifurcations give rise to the branched, tree-like architecture of the adult lung ([@bib26]). A population of rapidly proliferating progenitor cells resides at the tips of the epithelium throughout the branching process ("bud tip progenitors") ([@bib33]). This population, which expresses *Id2* and *Sox9* in mice, has the capability to differentiate into both mature airway and alveolar cell types. At early stages of branching morphogenesis, this population of progenitors gives rise to proximal airway cells, while at later time points these progenitors give rise to alveolar cells ([@bib33]).

Studies utilizing genetic mouse models have shown that lung branching morphogenesis and proximal-distal patterning are regulated by a series of complex mesenchymal-epithelial interactions that involve multiple signaling events, transcription factors, and dynamic regulation of the physical environment ([@bib19], [@bib29], [@bib40]). These studies have identified major roles for several signaling pathways in branching, including Wnt, fibroblast growth factor, bone morphogenic protein, Sonic hedgehog, retinoic acid (RA), and Hippo signaling, among others. However, due to the complex and intertwined nature of these signaling networks, perturbations in one pathway often affect signaling activity of others ([@bib19], [@bib29]).

These developmental principles, learned from studying model organism development, have been used as a guide to successfully direct differentiation of human pluripotent stem cells into differentiated lung lineages and three-dimensional lung organoids ([@bib27]) ([@bib12]). However, using this developmental information in a predictive manner to induce and maintain an epithelial bud tip progenitor cell population from hPSCs has remained elusive. For example, our own studies have shown that hPSCs can be differentiated into human lung organoids (HLOs) that possess airway-like epithelial structures and alveolar cell types; however, it was not clear if HLOs passed through a bud tip progenitor-like stage, mimicking all stages of normal development *in vivo* ([@bib10]). More recent evidence from others has demonstrated that putative bud tip progenitor cells may be induced from hPSCs; however, these cells were rare and were not assessed in detail ([@bib5]). Thus, generation of a robust population of bud tip progenitor cells from hPSCs would shed mechanistic light on how these cells are regulated, would provide a platform for further investigation into mechanisms of lung lineage cell fate specification, and would add a layer of control to existing directed differentiation protocols allowing them to pass through this developmentally important progenitor transition.

In the current study, we used isolated mouse epithelial bud tip cultures to identify conditions that maintained epithelial bud tip progenitors *in vitro.* These conditions were also tested using isolated human fetal epithelial bud tip progenitors cultured *in vitro*. We determined that FGF7 promoted an initial expansion of human epithelial bud tip progenitors, and that the addition of CHIR-99021 (a GSK3β inhibitor that acts to stabilize β-catenin) and all-*trans* RA (3-Factor conditions, herein referred to as "3F") were required for growth/expansion of human fetal bud tips as epithelial progenitor organoids that maintained their identity *in vitro.*

When applied to hPSC-derived foregut spheroid cultures, we observed that 3F conditions promoted growth into larger organoid structures with a patterned epithelium that had airway-like and bud tip-like domains. Bud tip-like domains could be preferentially expanded into "bud tip organoids" using serial passaging. hPSC-derived bud tip organoids had a protein expression and transcriptional profile similar to human fetal progenitor organoids. Finally, we demonstrated that hPSC-derived epithelial bud tip organoids can engraft into an injured mouse airway and undergo multilineage differentiation. Taken together, these studies provide an improved mechanistic understanding of human lung bud tip progenitor cell regulation and establish a platform for studying the maintenance and differentiation of lung bud tip progenitor cells.

Results {#sec2}
=======

Characterizing Human Fetal Lung Bud Tip Progenitors {#sec2.1}
---------------------------------------------------

In mice, epithelial bud tip progenitor cells express several transcription factors, including *Sox9*, *Nmyc*, and *Id2* ([@bib4], [@bib28], [@bib31], [@bib32], [@bib33], [@bib34]). However, recent studies have suggested that significant differences exist between murine and human fetal bud tip progenitor cells ([@bib8], [@bib30]). To confirm and extend these recent findings, we carried out an immunohistochemical analysis using well-established protein markers that are present during mouse lung development ([Figures 1](#fig1){ref-type="fig"}A--1C and [S1](#mmc1){ref-type="supplementary-material"}) on human lungs between 10 and 20 weeks of gestation. We also conducted RNA sequencing (RNA-seq) on freshly isolated epithelial lung bud tips, which were dissected to remove mesenchymal cells, to identify genes that were enriched in epithelial progenitors ([Figures 1](#fig1){ref-type="fig"}D and 1E). We note that our approach using manual and enzymatic dissection techniques were unlikely to yield pure epithelial cells, and likely possessed a small population of associated mesenchyme. Consistent with the developing mouse lung ([@bib32], [@bib34]), we observed that SOX9 is expressed in bud tip domains of the branching epithelium ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). In contrast to the developing murine lung, we observed SOX2 expression in these bud tip progenitor domains until 16 weeks of gestation, at which time SOX2 expression was lost from this population ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). We also observed expression of *ID2* by *in situ* hybridization ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}F), with expression becoming increasingly intense in the bud tips as branching progressed, up through 20 weeks gestation ([Figure S1](#mmc1){ref-type="supplementary-material"}F). Bud tips expressed nearly undetectable levels of pro-SFTPC at 10 and 12 weeks, with low levels of expression detected by 14 weeks ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Pro-SFTPC expression became more robust by 15 and 16 weeks and continued to increase in the bud tips until 20 weeks ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}D). SOX9+ bud tip cells were negative for several other lung epithelial markers including SFTPB, PDPN, RAGE, and HOPX ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}C--S1E). We also examined expression of several proximal airway markers, including P63, acetylated tubulin (AC-TUB), FOXJ1, SCGB1A1, and MUC5AC, and noted that expression was absent from the epithelial bud tip progenitors (negative staining data not shown). We did observe that PDPN and HOPX were expressed in the transition zone/small airways directly adjacent to the SOX9+ bud tip domain at all time points examined (10--20 weeks of gestation), but that this region did not begin to express the AECI maker RAGE until 16 weeks of gestation ([Figures 1](#fig1){ref-type="fig"}C, [S1](#mmc1){ref-type="supplementary-material"}B, S1C, and S1E). RNA-seq of isolated, uncultured human fetal epithelial lung bud tips (n = 2; 59 and 89 days gestation) supported protein-staining analysis of human fetal buds. Differential expression analysis to identify genes enriched in the human fetal bud tips (isolated human fetal epithelial bud tips versus whole adult lung) identified 7,166 genes that were differentially expressed (adjusted p value \< 0.01; [Figure 1](#fig1){ref-type="fig"}D). A curated heatmap highlights genes corresponding to [Figures 1](#fig1){ref-type="fig"}A--1C and previously established markers of lung epithelial cells ([Figure 1](#fig1){ref-type="fig"}E). Human fetal bud tips have recently been shown to have enrichment for 37 transcription factors ([@bib30]). In total, 20 of these 37 transcription factors were also enriched in our analysis ([Figure 1](#fig1){ref-type="fig"}F), and gene set enrichment analysis confirmed that this enrichment was highly significant (normalized enrichment score = −1.8, adjusted p value = 9.1 × 10^−5^). Combined, these data provided a profile of the protein and gene expression in human fetal lung buds prior to 15 weeks gestation (summarized in [Figure 1](#fig1){ref-type="fig"}G).Figure 1Characterization of Bud Tip Progenitors from 14 to 16 Weeks of Human Fetal Lung Development(A) Expression of SOX2 and SOX9 in human fetal lungs at 14 and 16 weeks of gestation. Scale bar represents 50 μm.(B) Expression of ID2 in human fetal lungs at 15 weeks gestation as identified by *in situ* hybridization. Scale bar represents 50 μm.(C) Expression of SOX9 along with pro-SFTPC, SFTPB, PDPN, HOPX, ABCA3, or RAGE in human fetal lung at 15 weeks. Scale bars represent 50 μm (low-magnification images) and 25 μm (high-magnification images).(D) Volcano plot of differentially expressed genes identified by comparing isolated, uncultured human fetal bud tips (n = 2 biological replicates; 8 and 12 weeks gestation) with whole adult human lung (publically available dataset). A total of 7,166 genes were differentially expressed (adjusted p value \< 0.01).(E) Heatmap showing expression of genes known to be expressed lung epithelial cells in isolated human fetal bud tips and whole adult human lung.(F) Heatmap showing expression of 37 human bud-tip enriched transcription factors ([@bib30]) in isolated human fetal bud tips and whole adult human lung. Twenty of the 37 transcription factors (^∗^) were statistically significantly enriched in isolated fetal bud tips.(G) Summary of markers expressed by bud tip cells in regions adjacent to the bud tips at 14--15 weeks gestation as identified by protein staining and *in situ* hybridization.

Murine Bud Tip Growth *In Vitro* {#sec2.2}
--------------------------------

To establish an experimental framework that would allow us to efficiently work with rare/precious human tissue samples, we first conducted a low-throughput screen using mouse epithelial bud tips to identify factors that promoted tissue expansion and maintenance of SOX9 expression. Epithelial bud tips were isolated from lungs of embryonic day (E) 13.5 *Sox9*-eGFP mice and cultured in a Matrigel droplet ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Isolated *Sox9*-eGFP lung bud tips were shown to express GFP and to have the same level of *Sox9* mRNA as their wild-type counterparts by qRT-PCR analysis ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C). Treating isolated E13.5 mouse bud tips with no growth factors (basal medium control) or individual factors identified from the literature as important for lung development showed that FGF7 robustly promoted growth, expansion, and survival of isolated buds for up to 2 weeks ([Figure S2](#mmc1){ref-type="supplementary-material"}D). Interestingly, the same concentration of FGF7 and FGF10 had different effects on lung bud outgrowth, an observation that could not be overcome even when buds were exposed to a 50-fold excess of FGF10 ([Figure S2](#mmc1){ref-type="supplementary-material"}E).

FGF7, CHIR-99021, and RA Are Sufficient to Maintain the Expression of SOX9 *In Vitro* {#sec2.3}
-------------------------------------------------------------------------------------

A lineage trace utilizing isolated epithelial bud tips from *Sox9*-*Cre*^ER^;*Rosa26*^Tomato^ mice showed that FGF7 promoted outgrowth of *Sox9*+ distal progenitors cells ([Figure S2](#mmc1){ref-type="supplementary-material"}F). However, *Sox9* mRNA and protein expression were significantly reduced over time ([Figures S2](#mmc1){ref-type="supplementary-material"}G and S2M).

We therefore sought to identify additional growth factors that could maintain expression of SOX9 *in vitro.* To do this, we grew bud tips in medium with all five factors included in our initial screen ("5F" media: FGF7, FGF10, BMP4, CHIR-99021, and RA), removed one growth factor at a time, and examined the effect on expression of *Sox9* and *Sox2* ([Figures S2](#mmc1){ref-type="supplementary-material"}H--S2J). Bud tips were grown in 5F minus one factor for 2 weeks in culture. Removing any individual factor, with the exception of FGF7, did not affect the ability of isolated buds to expand ([Figure S2](#mmc1){ref-type="supplementary-material"}H). qRT-PCR analysis showed that removing BMP4 led to a statistically significant increase in *Sox9* mRNA expression levels when compared with other culture conditions ([Figure S2](#mmc1){ref-type="supplementary-material"}I). Removing any other single factor did not lead to statically significant changes in *Sox9* expression ([Figure S2](#mmc1){ref-type="supplementary-material"}I). *Sox2* gene expression was generally low in all culture conditions ([Figure S2](#mmc1){ref-type="supplementary-material"}J).

Our data demonstrated that FGF7 is critical for *in vitro* expansion of isolated murine bud tips and removing BMP4 enhanced *Sox9* expression. We therefore screened combinations of the remaining factors to determine a minimal set of factors that could maintain high *Sox9* expression ([Figures S2](#mmc1){ref-type="supplementary-material"}K--S2N). Cultured buds treated with 4-factor ("4F") (FGF7, FGF10, CHIR-99021, and RA) or 3F conditions (FGF7, CHIR-99021, and RA) supported robust SOX9 protein and mRNA expression ([Figures S2](#mmc1){ref-type="supplementary-material"}L--S2N), with no significant differences between *Sox9* expression between these two groups. Therefore, a minimum set of three factors (FGF7, CHIR-99021, and RA) are sufficient to allow growth of mouse epithelial bud tip progenitor cells and to maintain *Sox9* expression *in vitro.*

*In Vitro* Growth and Maintenance of Human Fetal Distal Epithelial Lung Progenitors {#sec2.4}
-----------------------------------------------------------------------------------

We asked if conditions supporting mouse bud tip progenitors also supported growth and expansion of human bud tip progenitors *in vitro*. Distal epithelial lung buds were enzymatically and mechanically isolated from the lungs of three different biological specimens at 12 weeks of gestation (84--87 days; n = 3) and cultured in a Matrigel droplet ([Figures 2](#fig2){ref-type="fig"}A and 2B). When human bud tips were cultured *in vitro*, we observed that FGF7 promoted an initial expansion of tissue *in vitro* after 2 and 4 weeks, but structures began to collapse by 6 weeks in culture ([Figure S3](#mmc1){ref-type="supplementary-material"}A). All other groups tested permitted expansion and survival of buds as "fetal progenitor organoids" for 6 weeks or longer ([Figures 2](#fig2){ref-type="fig"}C and [S3](#mmc1){ref-type="supplementary-material"}A). A description of the nomenclature for different tissues/samples/organoids used in this manuscript can be found in [Table 1](#tbl1){ref-type="table"} of the Methods. Human fetal progenitor organoids exposed to 3F or 4F medium supported robust expression of the distal progenitor markers *SOX9, SOX2, ID2*, and *NMYC* ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C). In contrast, culture in only two factors (FGF7+CHIR-99021 or FGF7+RA) did not support robust bud tip progenitor marker expression ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C). qRT-PCR also showed that fetal progenitor organoids cultured in 3F or 4F medium expressed low levels of the proximal airway markers *P63, FOXJ1*, and *SCGB1A1* when compared with FGF7-only conditions ([Figures S3](#mmc1){ref-type="supplementary-material"}D and S3E).Figure 2FGF7, CHIR-99021, and RA Are Sufficient to Maintain Isolated Human Fetal Bud Tip Progenitor Cells *In Vitro*(A and B) Distal epithelial lung bud tips were isolated and cultured in Matrigel droplets. Scale bar represents 500 μm in (B).(C). Whole-mount bright-field image of human fetal organoids grown in "3F" medium (FGF7, CHIR-99021, and RA) at 2, 4, and 6 weeks. Scale bar represents 500 μm.(D) Protein staining of SOX2 and SOX9 in sections of fetal progenitor organoids grown in 3F medium. Scale bar represents 100 μm.(E) Whole-mount staining, confocal z stack imaging, and 3D rendering of SOX2 and SOX9 in fetal progenitor organoids grown in 3F medium. Scale bar represents 100 μm.(F) Pro-SFTPC after 4 weeks in culture in fetal progenitor organoids. Scale bars represent 50 μm.(G) *ID2* expression in fetal progenitor organoids after 4 weeks in culture as determined by *in situ* hybridization. Scale bar represents 50 μm.(H) Heatmap showing expression of genes known to be expressed lung epithelial cells in the whole adult human lung (publically available dataset), in isolated human fetal bud tips (n = 2; 8 and 12 weeks gestation) and in fetal progenitor organoids (n = 2; both 12 weeks gestation, cultured for 2 weeks).(I) Differential expression analysis (isolated fetal epithelial bud tips versus whole adult lung; fetal progenitor organoids versus whole adult lung) was used to identify the top 1,000 most highly upregulated genes from each comparison (log2 fold change \< 0; adjusted p value \< 0.05). Gene overlap was identified using a Venn diagram. Of all genes, 27.5% were common to both groups. A hypergeometric means test showed that the number of overlapping genes was highly significant (overlapping p value = 1.4 × 10^−278^).Table 1Description of the Nomenclature Used in This ManuscriptSample NomenclatureDescriptionPeripheral fetal lungthe distal/peripheral portion of the fetal lung (i.e., distal 0.5 cm) was excised from the rest of the lung using a scalpel. This includes all components of the lung (e.g., epithelial, mesenchymal, vascular).Isolated fetal bud tipthe bud peripheral portion of the fetal lung was excised with a scalpel and subjected to enzymatic digestion and microdissection. The epithelium was dissected and separated from the mesenchyme, but a small amount of associated mesenchyme likely remained.Fetal progenitor organoid3D organoid structures that arose from culturing isolated fetal epithelial bud tips.Foregut spheroid3D foregut endoderm structure as described in [@bib10]. Gives rise to patterned lung organoid (PLO) when grown in 3F medium.Patterned lung organoid (PLO)lung organoids that were generated by differentiating hPSCs, as described throughout the manuscript.Bud tip organoidorganoids derived from PLOs, enriched for SOX2/SOX9 co-expressing cells, and grown/passaged in 3F medium.

Collectively, our experiments demonstrated that FGF7, CHIR-99021, and RA represent a minimal set of additives required to maintain SOX9+/SOX2+ fetal progenitor organoids *in vitro.* Supporting mRNA expression data, we observed robust SOX9 and SOX2 protein expression as demonstrated by immunofluorescence in sections or by whole-mount staining after 4 weeks in culture ([Figures 2](#fig2){ref-type="fig"}D and 2E). Consistent with expression data in lung sections prior to 16 weeks gestation, we observed very weak pro-SFTPC protein expression in human bud tip progenitor organoids. Low levels of *ID2* mRNA were also detected using *in situ* hybridization ([Figures 2](#fig2){ref-type="fig"}F and 2G). Protein staining for several markers was not detected in fetal progenitor organoids treated for 4 weeks in 3F medium, including P63, FOXJ1, SCGB1A1, MUC5AC, HOPX, RAGE, and SFTPB (n = 8; negative data not shown), consistent with human fetal epithelial bud tips prior to 16 weeks gestation ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1E).

We also performed RNA-seq on tissue from the distal portion of fetal lungs (epithelium plus mesenchyme) (n = 3; 8, 12, and 18 weeks), on freshly isolated human epithelial bud tips (n = 2; 8, and 12 weeks) and on human fetal bud tip progenitor organoids grown in 3F medium for 4 weeks in culture (n = 2; 12 weeks, run with technical triplicates). Analysis revealed a high degree of similarity across samples when comparing epithelial gene expression ([Figure 2](#fig2){ref-type="fig"}H). In addition, we identified genes highly enriched in isolated fetal epithelial bud tips by conducting differential expression analysis on RNA-seq data. For this analysis, we compared whole human adult lung versus uncultured isolated lung buds (12 weeks gestation) and versus cultured fetal progenitor organoids (12 weeks gestation, cultured for 2 weeks). In these analyses, whole human lung was used as a "baseline," with the assumption that average expression of any given gene would be low due to the heterogeneous mixture of cells pooled together in the sample, providing a good comparator to identify genes that were enriched in fetal tissue and organoid samples. The top 1,000 upregulated genes in bud tips and in fetal progenitor organoids were identified (log2 fold change \< 0; adjusted p value \< 0.05). When comparing upregulated genes, we observed that 431 (27.5%) of the genes were commonly upregulated in both fetal bud tips and cultured fetal organoids, which was highly statistically significant (p = 1.4 × 10^−278^ determined by a hypergeometric test) ([Figure 2](#fig2){ref-type="fig"}I).

FGF7, CHIR-99021, and RA Induce a Bud Tip Progenitor-like Population of Cells from hPSC-Derived Foregut Spheroids {#sec2.5}
-----------------------------------------------------------------------------------------------------------------

Given the robustness by which 3F medium (FGF7, CHIR-99021, and RA) supported mouse and human epithelial lung bud tip growth and maintenance *in vitro*, we sought to determine whether these culture conditions could promote an epithelial lung tip progenitor-like population from hPSCs. NKX2.1+ ventral foregut spheroids were generated as described previously ([@bib10], [@bib11]), and were cultured in a droplet of Matrigel and overlaid with 3F medium. Spheroids were considered to be "day 0" on the day they were placed in Matrigel ([Figures 3](#fig3){ref-type="fig"}A and 3B). Foregut spheroids cultured in 3F medium generated patterned organoids (hereafter referred to as "hPSC-derived patterned lung organoids"; PLOs) that grew robustly ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B), demonstrating predictable growth patterns ([Figures S4](#mmc1){ref-type="supplementary-material"}C and S4D) and reproducible gene expression across several different embryonic and induced pluripotent stem cell lines (n = 4) ([Figures 3](#fig3){ref-type="fig"}B, [S4](#mmc1){ref-type="supplementary-material"}G, and S4H). PLOs survived for over 16 weeks in culture, and could be frozen, thawed, and re-cultured ([Figures S4](#mmc1){ref-type="supplementary-material"}E, S4E\', and S4F).Figure 3FGF7, CHIR-99021, and RA Generate Patterned Epithelial Lung Organoids from hPSCs(A) Schematic of approach to derive patterned lung organoids (PLOs) from human pluripotent stem cells.(B) Bright-field images of hPSC-derived foregut spheroids cultured in 3F medium (FGF7, CHIR-99021, and RA) and grown *in vitro.* Images taken at 2, 3, 5, 6, and 10 weeks. Images from a single experiment, representative of 6 experiments across 4 hPSC cell lines. Scale bars represent 200 μm.(C) Immunostaining for NKX2.1 and SOX2 in PLOs at 2, 6, and 16 weeks. Scale bars represent 50 μm.(D) Quantitative analysis of cells co-expressing NKX2.1 and SOX2 in PLOs at 2, 6, and 16 weeks, as shown in (B). Each data point (n = 5) represents a single organoid from one experiment, and the mean ± SEM is shown for each group. Data are representative of 6 experiments with 4 different cell hPSC lines.(E) Bright-field image of a patterned lung organoid after 6 weeks (45 days) in culture, showing distal budded regions and interior regions, and a schematic representing a patterned lung organoid, highlighting bud tip region and interior regions. Scale bar represents 200 μm.(F) PLOs co-stained for SOX9 and SOX2 protein expression by immunofluorescence. Inset: high magnification of boxed region. Scale bar represents 100 μm.(G) qRT-PCR analysis of *SOX9* and *SOX2* in undifferentiated hPSCs (H9 hESC line, n = 3 independent samples from one experiment), in foregut spheroids (FG; n = 3 independent samples obtained from one experiment; each sample contains ≥25 pooled spheroids), fetal progenitor organoids (n = 3 biological replicates \[12, 12, and 13 weeks\] and 3 technical replicates each) and patterned lung organoids (n = 3 independent samples obtained from 1 experiment; each sample contained ≥3 pooled organoids). Data are representative of 6 experiments with 4 different cell hPSC lines.(H) Pro-SFTPC and SOX9 co-expression in bud tip region of a PLO. Scale bars represent 50 μm.(I) *ID2* expression in PLOs after 40 days *in vitro* as determined by *in situ* hybridization. Scale bar represents 100 μm.(J) qRT-PCR analysis of *ID2* in undifferentiated hPSCs in undifferentiated hPSCs (H9 hESC line, n = 3 independent samples from 1 experiment), in foregut spheroids (FG; n = 3 independent samples obtained from 1 experiment; each sample contains ≥25 pooled spheroids), fetal progenitor organoids (n = 3 biological replicates \[12, 12, and 13 weeks\] with 3 technical replicates each) and patterned lung organoids (n = 3 independent samples obtained from 1 experiment; each sample contained ≥3 pooled organoids). Data are representative of 6 experiments with 4 different cell hPSC lines.(K) Interior regions of patterned lung organoids (top) and adult human airway (bottom) co-stained for SCGB1A1, acetylated tubulin (AC-TUB) and P63. Scale bars represent 100 μm (left panels, low magnification) or 50 μm (right panels, high magnification).(L) Interior regions of patterned lung organoids (top) and adult human airway (bottom) co-stained for MUC5AC and the epithelial marker β-catenin (βCAT). Scale bar in (K) also applies to images in (L); scale bars represent 100 μm (left panels, low magnification) or 50 μm (right panels, high magnification).(M and N) Percent of cells expressing MUC5AC or SCGB1A1, plotted as aggregate data (number of cells positive in all organoids/total cells counted in all organoids) (M), and for each individual patterned lung organoid counted (number of cells positive in individual organoid/all cells counted in individual organoid) (N). N = 5 organoids for each graph, from a single experiment of organoids derived from UM63-1 hPSC line. Data are representative of 6 experiments across 4 hPSC lines.

At 2 and 6 weeks, PLOs co-expressed NKX2.1 and SOX2 in \>99% of all cells (99.41% ± 0.82% and 99.06% ± 0.83%, respectively), while 16-week-old PLOs possessed 93.7% ± 4.6% NKX2.1+/SOX2+ cells ([Figures 3](#fig3){ref-type="fig"}C and 3D). However, PLOs at this later time point appeared less healthy ([Figure 3](#fig3){ref-type="fig"}B). Interestingly, no mesenchymal cell types were detected in PLO cultures at 2, 6, or 16 weeks by immunofluorescence (VIM, α-SMA, PDGFRα; negative immunostaining data not shown), and qRT-PCR analysis confirms very low expression of mesenchymal markers in PLOs generated from n = 3 hPSC lines ([Figure S4](#mmc1){ref-type="supplementary-material"}H).

PLOs also exhibited regionalized proximal-like and bud tip-like domains ([Figures 3](#fig3){ref-type="fig"}E and 3F). In 100% of analyzed PLOs (n = 8), peripheral budded regions contained cells that co-stained for SOX9 and SOX2, whereas interior regions of the PLOs contained cells that were positive only for SOX2 ([Figures 3](#fig3){ref-type="fig"}E and 3F). PLOs expressed similar levels of *SOX2* and *SOX9* compared with fetal progenitor lung organoids ([Figure 3](#fig3){ref-type="fig"}G). Budded regions of PLOs also contained SOX9+ cells that weakly co-expressed pro-SFTPC, and *ID2* based on *in situ* hybridization and qRT-PCR ([Figures 3](#fig3){ref-type="fig"}H--3J).

Interior regions of PLOs contained a small number of cells that showed positive immunostaining for the club cell marker SCGB1A1 (9%) and the goblet cell marker MUC5AC (1%), with similar morphology to adult human proximal airway secretory cells ([Figures 3](#fig3){ref-type="fig"}K--3N). No multiciliated cells were present, as AC-TUB was not localized to cilia ([Figure 3](#fig3){ref-type="fig"}K) and FOXJ1 staining was absent (data not shown). In addition, the basal cell marker P63 was absent from PLOs ([Figure 3](#fig3){ref-type="fig"}K), as was staining for markers of lung epithelial cell types including HOPX, RAGE, PDPN, ABCA3, SFTPB, and chromagranin A (CHGA) (negative data not shown).

Expansion of Epithelial Tip Progenitor-like Cells from PLOs {#sec2.6}
-----------------------------------------------------------

PLOs gave rise to epithelial cysts after being passaged by mechanical shearing through a 27-gauge needle, followed by embedding in fresh Matrigel and growth in 3F medium ([Figures 4](#fig4){ref-type="fig"}A and 4B). PLOs were successfully needle passaged as early as 2 weeks, and as late as 10 weeks, with similar results. Needle-passaged cysts can be generated from hPSCs in as little as 24 days (9 days to generate foregut spheroids, 14 days to expand PLOs, and 1 day to establish cysts from needle-passaged organoids) ([Figure 4](#fig4){ref-type="fig"}A). Needle-passaged epithelium re-established small cysts within 24 hours and could be serially passaged every 7--10 days ([Figure 4](#fig4){ref-type="fig"}C). The cysts that formed after needle passaging were NKX2.1+ ([Figure S5](#mmc1){ref-type="supplementary-material"}A) and cells co-expressed SOX2 and SOX9 ([Figures 4](#fig4){ref-type="fig"}D and 4E). Based on these protein-staining patterns, we refer to these cysts as "bud tip organoids." Compared with PLOs, bud tip organoids possessed a much higher proportion of SOX9+ cells (42.5% ± 6.5%, n = 5; versus 88.3% ± 2.3%, n = 9; [Figure 4](#fig4){ref-type="fig"}E) and proliferating cells, as assessed by KI67 immunostaining (38.24% ± 4.7%, n = 9 for bud tip organoids versus 4.9% ± 0.6%, n = 5 for PLOs; [Figures 4](#fig4){ref-type="fig"}F--4I). In PLOs, we noted that proliferation was largely restricted to SOX9+ budded regions, but only a small proportion of SOX9+ cells were proliferating (8.1% ± 0.9%, n = 5), whereas bud tip organoids had a much higher proportion of proliferative SOX9+ cells (40.2% ± 4.3%, n = 9) ([Figure 4](#fig4){ref-type="fig"}I). Together, these data suggest that needle passaging enriches the highly proliferative bud tip regions of PLOs.Figure 4Proliferative SOX9+/SOX2+ Progenitors Can Be Expanded from Patterned Lung Organoids(A) Schematic of approach passage PLOs and expand bud tip organoids.(B) Needle-sheared epithelial fragments were replated in a fresh Matrigel droplet that subsequently formed cystic structures, called "bud tip organoids." Scale bar represents 1 mm.(C) Quantitative assessment of organoid passaging and expansion. One single patterned lung organoid was needle passaged into 6 wells (passage 1), generating 75 new bud tip organoids in total (average 12.5 per well). A single well of the resulting bud tip organoids was then passaged into 6 new wells after 2 weeks in culture (1:6 split ratio), generating 200 new organoids in total (average 33 per well). This 1:6 passaging was carried out two additional times, every 1--2 weeks for up to 4 passages before growth plateaued. Three technical replicates were performed for expansion experiments using patterned lung organoids generated from the UM63-1 hPSC line; the graph plots the mean ± SEM. Data are representative of 6 experiments across 4 hPSC lines.(D) Immunostaining for SOX9 and SOX2 in bud tip organoids. Scale bar represents 50 μm.(E) Quantitation of the percent of SOX9+ cells in PLOs and bud tip organoids (number of SOX9+ cells/total cells). Each data point represents an independent organoid (n = 5 organoids) derived from a single experiment using H9 hPSC line and graphs indicate the mean ± SEM for each experimental group. Data are representative of 6 experiments across 4 hPSC lines.(F and G) Immunostaining for KI67 and SOX9 in patterned lung organoids (F) and bud tip organoids (G). Scale bar represents 100 μm.(H) Quantitation of the percent of all cells that were KI67+ in patterned and bud tip organoids (number of KI67+ cells/total cells).(I) Quantitation of the percent of proliferating SOX9+ cells in patterned and bud tip organoids (number of KI67+/SOX9+ cells/total cells).(H and I) Each data point represents an independent organoid (n = 5 patterned lung organoids and n = 9 bud tip organoids) derived from a single experiment using H9 hPSC line and graphs indicate the mean ± SEM for each experimental group. Data are representative of 6 experiments across 4 hPSC lines.(J) Principal component analysis of RNA-seq data to compare the global transcriptome of hPSCs (n = 3 independent replicates of H9 hPSCs), foregut spheroids (n = 3 independent replicates of H9 hPSCs-derived spheroids. Each replicate contained ≥25 pooled spheroids), hPSC-derived patterned lung organoids (n = 3 independent replicates of H9 hPSCs-derived patterned lung organoids; each replicate contained n ≥ 3 pooled organoids), hPSC-derived bud tip organoids (n = 3 independent replicates of H9 hPSCs-derived bud tip organoids; each replicate contained n ≥ 3 organoids), whole peripheral (distal) fetal lung (n = 3; 8, 12, and 18 weeks), freshly isolated (uncultured) fetal lung buds (n = 2; 8 and 12 weeks gestation) and fetal progenitor organoids (n = 2; both 12 weeks gestation and cultured for 2 weeks). All biological replicates were run in technical triplicate.(K) Heatmap showing expression of genes known to be expressed in lung epithelial cells in freshly isolated (uncultured) fetal lung buds and fetal progenitor organoids cultured for 2 weeks.(L--N) Differential expression analysis of (1) isolated fetal bud tips versus whole adult lung, (2) fetal progenitor organoids versus whole adult lung, and (3) bud tip organoids versus whole adult lung was used to identify the top 1,000 most highly upregulated genes from each comparison (log2 fold change \< 0; adjusted p value \< 0.05). A Venn diagram illustrates common upregulated genes in (L) isolated bud tips and bud tip organoids, (M) fetal progenitor organoids and bud tip organoids, (N) isolated bud tips, fetal progenitor organoids, and bud tip organoids. (L) hypergeometric means test found that the shared gene overlap was highly significant (overlapping p value = 9.3e-901). (M) Hypergeometric means test found that the shared gene overlap was highly significant (overlapping p value = 1.2e-1,021). (N) A total of 285 overlapping genes were shared between the three groups. These genes represented 14.3% of all genes included in the comparison. A small subset of genes previously associated with human or mouse bud-tip progenitor cells are highlighted as "Selected overlapping genes" (L--N).

Bud tip organoids were further characterized using *in situ* hybridization and immunofluorescence ([Figures S5](#mmc1){ref-type="supplementary-material"}B--S5D). Bud tip organoids exhibited protein-staining patterns consistent with 12--14 week fetal lungs, including the absence of HOPX, RAGE, PDPN, and ABCA3, while we did observe low *ID2* expression ([Figures S5](#mmc1){ref-type="supplementary-material"}B--S5D). Furthermore, no positive protein staining was detected for the proximal airway markers P63, FOXJ1, AC-TUB, MUC5AC, SCGB1A1, or CHGA (negative data not shown).

We then conducted unbiased analysis of bud tip organoids using RNA-seq to compare (1) hPSC-derived bud tip organoids; (2) whole peripheral (distal) human fetal lung tissue; (3) freshly isolated fetal bud tips and human fetal lung progenitor organoids; (4) undifferentiated hPSCs; and (5) hPSC-derived lung spheroids. Principal-component analysis and Spearman\'s correlation clustering revealed the highest degree of similarity between hPSC-derived bud tip organoids, PLOs, and human fetal organoids ([Figures 4](#fig4){ref-type="fig"}J and [S5](#mmc1){ref-type="supplementary-material"}E). Interestingly, freshly isolated bud tips and whole distal human fetal lungs clustered together, while all cultured tissues (bud tip organoids, PLOs, and fetal progenitor organoids) clustered together, likely reflecting gene expression similarities driven by the tissue culture environment. This analysis highlights a high degree of molecular similarity between human fetal and hPSC-derived organoids grown *in vitro* ([Figure 4](#fig4){ref-type="fig"}J). A curated heatmap shows a high degree of similarity in gene expression of lung epithelial markers between the whole fetal lung, fetal progenitor organoids, PLOs, and bud tip organoids ([Figure 4](#fig4){ref-type="fig"}K).

Differential expression of RNA-seq data was also used to interrogate the relationship between tissues. We obtained upregulated genes from the following comparisons: (1) uncultured, freshly isolated lung buds (8 and 12 weeks gestation) versus whole adult lung tissue; (2) cultured fetal progenitor organoids (12 weeks gestation, cultured for 2 weeks) versus whole adult lung tissue; and (3) hPSC-derived bud tip organoids versus whole adult lung tissue. The top 1,000 upregulated genes in each of the three groups were identified (log2 fold change \< 0; adjusted p value \< 0.05), and overlapping genes were identified ([Figures 4](#fig4){ref-type="fig"}L and 4M). A hypergeometric means test found that overlap of enriched genes from isolated human bud tips and hPSC-derived bud tip organoids were highly significant, with 377 (23.2%) overlapping genes (p = 9.3e-901; [Figure 4](#fig4){ref-type="fig"}L). Overlap between cultured fetal progenitor organoids and hPSC-derived bud tip organoids was also highly significant, with 477 (31.3%) overlapping genes (p = 1.2e-1,021) ([Figure 4](#fig4){ref-type="fig"}M). Of note, when all three groups were compared, a core group of 285 common upregulated genes were identified, representing 14.3% of genes. Of these 285, several have been associated with human or mouse fetal bud tips ([@bib30], [@bib34]) ([Figure 4](#fig4){ref-type="fig"}N; *COL2A1, ETV4, E2F8, FGF20, HMGA2, MYBL2, RFX6, SALL4, SOX9,* and *SOX11*).

hPSC-Derived Bud Tip Organoids Maintain Multilineage Potential *In Vitro* and *In Vivo* {#sec2.7}
---------------------------------------------------------------------------------------

To demonstrate that hPSC-derived organoids have *bona fide* progenitor potential, we took approaches to differentiate them *in vitro* ([Figure 5](#fig5){ref-type="fig"}) and by transplanting them into injured mouse lungs *in vivo* ([Figures 6](#fig6){ref-type="fig"} and [S6](#mmc1){ref-type="supplementary-material"}). For these experiments, we used induced pluripotent stem cells (iPSC)-derived foregut spheroids to generate bud tip organoids (iPSC line 20-1 (iPSC20-1) \[[@bib36]\]).Figure 5Bud Tip Organoids Retain Multilineage Potential *In Vitro*(A) Schematic of experimental setup. iPSC20-1 bud tip organoids were initially cultured in 3F medium and subsequently grown in 3F medium or medium containing FGF7 alone ("differentiation media") for 24 days.(B) Bright-field images of bud tip organoids growing in 3F medium (left) or FGF7-differentiation medium (right). Scale bar represents 500 μm.(C) NKX2.1 immunofluorescence of bud tip organoids grown in FGF7-differentiation medium for 24 days. Scale bar represents 50 μm.(D) SOX9 and SOX2 immunofluorescence of bud tip organoids grown in FGF7-differentiation medium for 24 days. Scale bar represents 50 μm.(E) qRT-PCR analysis of bud tip organoids grown in 3F or FGF7-differentiation medium showing expression of several genes expressed in the lung epithelium. Data are shown as fold change relative to 3F-grown undifferentiated bud tip organoids. Each data point represents an independent sample (n = 3) obtained from one experiment derived from iPSC 20-1 hPSC line; each sample contained ≥3 pooled organoids. Data are representative of 5 experiments across 2 hPSC lines (iPSC20-1 and H9).(F) qRT-PCR analysis of bud tip organoids grown in 3F or FGF7-differentiation medium, along with whole distal fetal lung and cultured whole fetal intestine as reference tissues, showing expression of several genes expressed in the lung epithelium. Data are shown as a.u. Values lower than 10^−3^ were considered undetected. Each data point in bud tip organoid groups represents an independent sample (n = 3) obtained from one experiment derived from iPSC 20-1 hPSC line; each sample contained ≥3 pooled organoids. Data are representative of 5 experiments across 2 hPSC lines (iPSC20-1 and H9). Whole human distal lung samples (n = 3) were taken from 87, 87, and 101 day gestation, and 3 independent samples of human fetal duodenum tissue were used as a comparison.(G) Immunostaining for airway markers in the adult human lung, and in bud tip organoids grown in FGF7-differentiation medium. Markers are shown for goblet cells (MUC5AC, MUC5B), club cells (SCGB1A1, PLUNC), and neuroendocrine cells (synaptophysin \[SYN\], CHGA). Scale bars represents 50 μm.(H) Transmission electron microscopy through a bud tip organoid grown in FGF7-differentiation medium showing mucus-filled vacuoles characteristic of goblet cells. Scale bar represents 100 nm.(I) Immunostaining for alveolar markers in the adult human lung, and in bud tip organoids grown in FGF7-differentiation medium. Markers are shown for AECI cells (PDPN, HOPX) and AECII cells (pro-SFTPC, SFTPB, ABCA3). Scale bars represent 50 μm.(J) Transmission electron microscopy of a human fetal lung at 13 weeks of gestation, and of a bud tip organoid grown in FGF7-differentiation medium showing immature lamellar bodies surrounded by monoparticulate glycogen, characteristic of immature AECII cells. Scale bars represent 100 nm.(K and L) Quantitation of cell type markers in bud tip organoids grown in differentiation medium plotted as aggregate data (numbers at top of bars represent positive cells/total cells counted across five individual organoids) (H), and as individual data per organoid (number of positive cells per organoid) (I). Graphs indicate the mean ± SEM. Data are from a single differentiation experiment derived from iPSC 20-1 hPSC line and each data point represents an individual organoid (n = 5 organoids). Data are representative of five experiments across two hPSC lines (iPSC20-1 and H9).(M) Summary of putative differentiated lung epithelial cell types generated *in vitro*.Figure 6Engraftment of hPSC-Derived Bud Tip Progenitor Organoid Cells into the Injured Mouse Airway(A) Schematic of experimental design. Immunocompromised NSG male mice were injected with 300 mg/kg of naphthalene. Twenty-four hours post injury, mice were randomly assigned to receive an intratracheal injection of 600,000 single cells isolated from bud tip organoids generated from the iPSC 20-1 tet-O GFP line, undifferentiated H9 hPSCs, or no injection of cells. Doxycycline (1 mg/mL) was added to the drinking water for the final week to induce expression of the tet-O GFP construct. Lungs were analyzed 6 weeks after cell injection.(B) Percent of lungs from surviving animals in each group exhibiting engraftment of human cells after 6 weeks, as determined by NuMA and GFP protein staining.(C and D) Engraftment was assessed based on human-specific expression on NuMA and GFP in three independent histological sections from each surviving mouse. (C) The number of engraftment cell patches observed in 15 surviving animals in the group receiving bud tip organoid cells. (D) Quantitation of the number of human cells in each engrafted cell patch, in each mouse. Every data point represents the number of cells in a single patch of cells.(E) H&E staining documenting the lung epithelial airway injury in control mice (injury, no cell injection), and in mice that received bud tip organoids, or undifferentiated iPSC injections. Engrafted patches of human cells were obvious (arrow), and were confirmed in serial sections using human-specific antibodies. Scale bar represents 50 μm for all images.(F) Immunostaining for NuMA and GFP in human fetal lungs and in bud tip organoid transplanted lungs. Scale bar represents 50 μm.(G) Bud tip organoid transplanted lung showing several images stitched together to generate a large panel demonstrating multiple sites of engraftment (denoted by asterisks), marked by NuMA and/or GFP, in the upper airway. High-magnification insets are shown. Scale bar represents 100 μm.(H) Immunostaining of adult human lung tissue and bud tip organoid transplanted lung tissue showing immunostaining for several lung epithelial markers, including SOX9 and SOX2, multiciliated cell markers AC-TUB and FOXJ1, goblet cell markers MUC5AC and MUC5B, club cell markers SCGB1A1 and PLUNC. Arrow highlights a cell co-expressing SCGB1A1/PLUNC. Scale bar represents 50 μm.(I) Bright-field microscopic image showing immunohistochemistry for NuMA in a patch of engrafted cells, counterstained using eosin to visualize tufts of multiple cilia. Scale bar represents 50 μm.(J) Quantification of cell type markers in bud tip organoid transplanted lungs after 6 weeks. Data are plotted as aggregate data (numbers at top of bars represent positive cells/total cells counted across three engrafted lungs). Aggregated data from three non-serial sections for mouse 7, 11, and 12 is plotted.

*In Vitro* Differentiation {#sec2.8}
--------------------------

Since we were interested in investigating the potential of bud tip progenitor organoids to give rise to any lung epithelial lineage, we reasoned that withdrawing CHIR-99021 and RA may allow the cells to stochastically differentiate. Therefore, bud tip organoids were split into two treatment groups: 3F medium or FGF7-only for 23 days ([Figure 5](#fig5){ref-type="fig"}A). At the end of the experiment, control bud tip organoids maintained a clear, thin epithelium with a visible lumen, whereas FGF7-differentiated organoids appeared as dense cysts with mucus-like material inside of some organoids ([Figure 5](#fig5){ref-type="fig"}B). FGF7-differentiated organoids remained NKX2.1+/ECAD+ and SOX2+, signifying that they retained a lung epithelial identity, but showed decreased SOX9 protein expression ([Figures 5](#fig5){ref-type="fig"}C and 5D). Gene expression analysis using qRT-PCR to compare 3F (undifferentiated) versus FGF7-differentiated organoids showed significant increases of genes expressed in differentiated airway and alveolar epithelium ([Figure 5](#fig5){ref-type="fig"}E). When further compared with the whole distal portion of human fetal lung (positive control) and cultured human fetal duodenum (negative control), differentiated bud tip organoids showed a large increase relative to 3F in many genes associated with differentiated epithelial cells, with many genes trending toward levels seen in the whole fetal lung ([Figure 5](#fig5){ref-type="fig"}F).

Protein staining for airway and alveolar markers was carried out on human lung tissue samples as a reference and in FGF7-differentiated organoids ([Figures 5](#fig5){ref-type="fig"}G and 5I). We observed that cells within FGF7-differentiated organoids expressed proximal airway markers, including the goblet cell markers MUC5AC and MUC5B, the club cell markers SCGB1A1, and the neuroendocrine cell markers SNY and CHGA ([Figure 5](#fig5){ref-type="fig"}F). Of note, we observed that SCGB1A1 and PLUNC were co-expressed in only a small subset of club cells in the adult lung, whereas many club cells were marked only with SCGB1A1 ([Figure 5](#fig5){ref-type="fig"}G). We did not observe P63, FOXJ1, or cilia with AC-TUB staining in FGF7-differentiated organoids (negative data not shown). Transmission electron microscopy (TEM) also revealed cells with mucus-containing vesicles characteristic of goblet cells within FGF7-differentiated organoids ([Figure 5](#fig5){ref-type="fig"}H). Immunostaining for alveolar markers revealed cells positive for AECI markers PDPN and HOPX, as well as cells double-positive for AECII markers pro-SFTPC and SFTPB and pro-SFTPC and ABCA3 ([Figure 5](#fig5){ref-type="fig"}I). Of note, TEM also revealed putative lamellar bodies that were similar to those seen in 13 week human fetal lungs ([Figure 5](#fig5){ref-type="fig"}J). In both tissues, putative lamellar bodies were characteristically surrounded by what appears to be monoparticulate glycogen ([@bib37]). Both iPSC-derived and human fetal tissue lamellar bodies appear to be immature, and did not possess the typical concentric lamellae of mature structures ([@bib39]) ([Figure 5](#fig5){ref-type="fig"}J). Based on both immunofluorescence and TEM data, it is most likely that the alveolar cell types observed in FGF7-differentiated organoids are reminiscent of an immature cell, and may require more specific conditions to further mature the primitive AECI and AECII cells.

Cells expressing cell-type-specific lung epithelial markers were quantitated within FGF7-differentiated organoids, showing that organoids possessed cells expressing the alveolar markers: PDPN, 8.6% of total cells; HOPX, 5.9% of total cells; SFTPB, ∼45% of total cells; pro-SFTPC, ∼45% of total cells; and ABCA3, 6.3% of total cells ([Figures 5](#fig5){ref-type="fig"}K and 5L). Many cells expressed airway markers: 43.2% of cells stained positive for nuclear SOX2, but not SOX9 ([Figures 5](#fig5){ref-type="fig"}K and 5L), 26.8% of cells stained positive for MUC5AC, while 7% of cells were positive for the club cell marker SCGB1A1, while FOXJ1 and P63 were absent ([Figures 5](#fig5){ref-type="fig"}K and 5L). In addition, 2.0% of cells expressed very clear co-staining for CHGA and synaptophysin, markers for neuroendocrine cells ([Figures 5](#fig5){ref-type="fig"}G, 5K, and 5L).

*In Vivo* Engraftment {#sec2.9}
---------------------

We next sought to explore the differentiation potential of hPSC-derived bud tip progenitor organoids by transplanting them into the airways of injured mouse lungs ([Figures 6](#fig6){ref-type="fig"} and [S6](#mmc1){ref-type="supplementary-material"}). Recent studies have shown that damaging the lung epithelium promotes engraftment of adult human lung epithelial cells ([@bib15]).

Interestingly, while we observed engrafted cells in the mouse airway 7 days post injury ([Figures S6](#mmc1){ref-type="supplementary-material"}A--S6E), 79% of engrafted human cells were still co-labeled by nuclear SOX2 and nuclear SOX9 and remained highly proliferative ([Figures S6](#mmc1){ref-type="supplementary-material"}F--S6J). Immunofluorescent staining showed that, of the small proportion of cells positive for only SOX2, 42.8% expressed the club cell marker SCGB1A1, and 25% expressed the goblet cell marker MUC5AC ([Figures S6](#mmc1){ref-type="supplementary-material"}K--S6N), a large increase when compared with bud tip organoid controls ([Figures S6](#mmc1){ref-type="supplementary-material"}O and S6P). Multiciliated cells were not observed (negative FOXJ1 staining in [Figure S6](#mmc1){ref-type="supplementary-material"}K), nor were basal cells or alveolar cell markers (basal cells: P63, KRT5; AECI: HOPX, PDPN, RAGE; AECII: pro-SFTPC, SFTPB, ABCA3; negative staining not shown). Collectively, our data suggested that hPSC-derived lung bud tip progenitor-like cells can engraft into the injured airway; however, the majority of engrafted cells (79%; [Figures S6](#mmc1){ref-type="supplementary-material"}F and S6G) retained expression of SOX9 after 7 days.

To further determine whether engrafted cells could differentiate into lung cell lineages, we carried out a long-term engraftment experiment where lungs were harvested 6 weeks after injection of cells ([Figure 6](#fig6){ref-type="fig"}). Mice received naphthalene injury 24 hr prior to intratracheal injection of 600,000 dissociated bud tip organoid cells derived from iPSCs (iPSC20.1 tet-O GFP) ([Figure 6](#fig6){ref-type="fig"}A). Doxycycline was given on the final week of the experiment to induce expression from the tet-O-GFP transgene in the iPSC-derived cells. Experimental cohorts included: injury plus no cell injection (n = 8 surviving animals); injury plus undifferentiated hPSC injection (n = 4 surviving animals); and injury plus bud tip organoid cell injection (n = 15 surviving animals) ([Figure 6](#fig6){ref-type="fig"}B). Of the 15 surviving mice that received bud tip organoid injections, 8 showed patches of NUMA+/GFP+ cells that engrafted into the airway ([Figures 6](#fig6){ref-type="fig"}C, 6D, 6F, and 6G). The number of engrafted cell patches ([Figure 6](#fig6){ref-type="fig"}C) and the number of cells per patch ([Figure 6](#fig6){ref-type="fig"}D) varied across individual mice. Lungs from animals in all experimental groups successfully recovered from the injury ([Figure 6](#fig6){ref-type="fig"}E). Engrafted human cells were not observed in the "no cell injection" nor the "undifferentiated hPSC injection" cohorts ([Figure 6](#fig6){ref-type="fig"}B), as determined by NUMA+/GFP+ staining ([Figures 6](#fig6){ref-type="fig"}F and 6G). While two mice that showed successful engraftment of bud tip organoid cells within the airway exhibited a total of four small patches of engrafted cells in the bronchioles, the overwhelming majority of engrafted cells were found in the trachea and primary/secondary bronchi of mice. The rare engrafted cells within the bronchioles stained positive for proximal cell markers SOX2, MUC5AC, or FOXJ1/AC-TUB (data not shown).

We conducted immunostaining for several lung epithelial markers to determine if engrafted tissue had differentiated, and we compared staining patterns with adult human lung tissue ([Figure 6](#fig6){ref-type="fig"}H). Immunostaining of the injury group that did not receive cells was also examined ([Figures S6](#mmc1){ref-type="supplementary-material"}Q and S6R). We noted that engrafted human cells expressed low levels of NKX2.1, consistent with the human airway, where the majority of cells expressed very low levels of NKX2.1 ([Figures S6](#mmc1){ref-type="supplementary-material"}S and S6T). Engrafted human cells (as determined by GFP or NuMA expression) also expressed SOX2, but not SOX9, suggesting that these cells had differentiated into an airway fate ([Figure 6](#fig6){ref-type="fig"}H). Consistent with this observation, we observed engrafted human cells that possessed multiple cilia and co-expressed NuMA and multiciliated cell markers, Ac-Tub, and FOXJ1 ([Figure 6](#fig6){ref-type="fig"}H), as determined in histological sections ([Figure 6](#fig6){ref-type="fig"}I). We also observed human cells expressing goblet cell markers MUC5AC and MUC5B. Finally, we observed human cells expressing the club cell marker SCGB1A1, but not PLUNC. Interestingly, we noted that PLUNC only marked a small subset of club cells in the human airway, suggesting that there is an underappreciated heterogeneity within this population in the human lung ([Figure 6](#fig6){ref-type="fig"}H). Quantitation of immunostaining confirmed that 100% of engrafted human cells were SOX2+, with roughly 75% of cells adopting a mucus-producing phenotype, ∼13% adopting a ciliated cell profile, and ∼0.5% exhibiting a neuroendocrine cell profile ([Figure 6](#fig6){ref-type="fig"}H). We did not find evidence that engrafted human cells expressed the basal cell marker P63 nor alveolar cell specific markers (negative data not shown).

Discussion {#sec3}
==========

The ability to study human lung development, homeostasis, and disease is limited by our ability to carry out functional experiments in human tissues. This has led to the development of many different *in vitro* model systems using primary human tissue, and using cells and tissues derived from hPSCs ([@bib12], [@bib27]). Current approaches to differentiate hPSCs have used many techniques, including the stochastic differentiation of lung-specified cultures into many different lung cell lineages ([@bib5], [@bib20], [@bib41]), fluorescence-activated cell sorting-based methods to purify lung progenitors from mixed cultures followed by subsequent differentiation ([@bib16], [@bib21], [@bib22], [@bib24], [@bib25]), and by expanding three-dimensional ventral foregut spheroids into lung organoids ([@bib11], [@bib10]). Many or all, of these approaches rely on the differentiation of a primitive NKX2.1+ lung progenitor cell population, followed by subsequent differentiation into different cell lineages. However, during normal development, early NKX2.1-specified lung progenitors transition through a SOX9+ bud tip progenitor cell state on their way to terminal differentiation into both alveolar and airway cell fates ([@bib2], [@bib33]). Despite the developmental importance of this bud tip progenitor, differentiation of a similar progenitor from hPSCs has remained elusive. For example, several studies have identified robust methods to sort and purify lung epithelial progenitor cells from a mixed population ([@bib16], [@bib22], [@bib25]); however, whether or not these populations represent transition through an epithelial bud tip-like state is unknown. Thus, our findings demonstrating that hPSCs can be induced into a bud tip-like progenitor state represents an important step toward faithfully mimicking embryonic lung development *in vitro*. Our studies also suggest that the ability to induce, *de novo*, robust populations of cells from hPSCs that do not rely on specialized sorting or purification protocols represents biologically robust experimental findings. These findings can be used in a manner that predicts how a naive cell will behave in the tissue culture dish with a high degree of accuracy, and across multiple cell lines ([@bib7], [@bib17], [@bib36]).

Our studies also identified significant species-specific differences between the human and fetal mouse lung. Differences included both gene/protein expression differences, as well as functional differences when comparing how cells responded to diverse signaling environments *in vitro.* These mouse-human differences highlight the importance of validating observations made in hPSC-derived tissues by making direct comparisons with human tissues, as predictions or conclusions about human cell behavior based on results generated from the developing mouse lung may be misleading.

Our experimental findings, in combination with previously published work, have also raised new questions that may point to interesting avenues for future mechanistic studies to determine how specific cell types of the lung are generated. Previously, we have shown that lung organoids grown in high concentrations of FGF10 predominantly give rise to airway-like tissues, with a small number of alveolar cell types and a lack of alveolar structure, and these organoids also possess abundant mesenchymal cell populations ([@bib11], [@bib10]). Here, our results suggest that high concentrations of FGF10 alone do not play a major role in supporting robust growth of epithelial bud tip progenitor cells. We also note that lung organoids grown in high FGF10 possess P63+ basal-like cells ([@bib10]), whereas bud tip organoids grown in 3F medium lack this population. These findings suggest that we still do not fully appreciate how various signaling pathways interact to control cell fate decisions or expansion of mesenchymal populations, and lay the groundwork for many future studies.

Taken together, our current work has identified a signaling network required for the induction, expansion, and maintenance of hPSC-derived lung epithelial bud tip progenitors. Simple needle passaging allowed us to expand a nearly homogeneous population of proliferative bud tip-like progenitor cells for over 16 weeks in culture, which remained multipotent *in vitro* and which were able to engraft into injured mouse lungs, terminally differentiate, and respond to systemic factors. The current study thus offers a robust and reproducible method to generate and maintain epithelial bud tip progenitors, which will facilitate future studies aimed at elucidating fundamental developmental mechanisms regulating human lung progenitor cells, and which may have applicability to regenerative medicine in the future.

Experimental Procedures {#sec4}
=======================

Mouse Models {#sec4.1}
------------

All animal research was approved by the University of Michigan Committee on Use and Care of Animals. Lungs from Sox9-eGFP (MGI ID: [3844824](mgi:3844824){#intref0010}), Sox9CreER; Rosa^Tomato/Tomato^ (MGI ID: [5009223](mgi:5009223){#intref0015} and [3809523](mgi:3809523){#intref0020}) ([@bib23]), or wild-type lungs from CD1 embryos (Charles River) were dissected at E13.5. Immunocompromised NSG mice (8- to 10-week-old) (Jackson Laboratory strain no. 0005557) were used for engraftment studies. Pilot studies identified that females were more sensitive to naphthalene and died at a higher rate, therefore male mice were used for engraftment experiments.

Human Lung Tissue {#sec4.2}
-----------------

All research utilizing human tissue was approved by the University of Michigan institutional review board. Additional information can be found in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Cell Lines and Culture Conditions {#sec4.3}
---------------------------------

### Mouse and Human Primary Cultures {#sec4.3.1}

Epithelial bud tips were isolated as essentially as described previously ([@bib9]), and see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Isolated mouse bud tips were cultured in 4--6 μL droplets of Matrigel, covered with medium, and kept at 37°C with 5% CO~2~. Isolated human fetal lung bud tips were cultured in 25--50 μL droplets of Matrigel, covered with medium, and kept at 37°C with 5% CO~2~. Culture medium was changed every 2--4 days.

### Generation and Culture of hPSC-Derived Lung Organoids {#sec4.3.2}

The University of Michigan Human Pluripotent Stem Cell Research Oversight Committee approved all experiments using human embryonic and induced pluripotent stem cell (hESC, iPSC) lines. PLOs were generated from four independent pluripotent cell lines in this study: hESC line UM63-1 (NIH registry no. 0277) was obtained from the University of Michigan and hESC lines H9 and H1 (NIH registry no. 0062 and no. 0043, respectively) were obtained from the WiCell Research Institute. iPSC20.1 was described previously ([@bib36]). ESC lines were routinely karyotyped to ensure normal karyotype and ensure the sex of each line (H9, XX; UM63-1, XX; H1, XY). All cell lines are routinely monitored for mycoplasma infection monthly using the MycoAlert Mycoplasma Detection Kit (Lonza). Stem cells were maintained as described previously ([@bib36]), and ventral foregut spheroids were generated as described previously ([@bib11], [@bib10]). Following differentiation, free-floating foregut spheroids were collected from differentiated stem cell cultures and plated in a Matrigel droplet on a 24-well tissue culture grade plate. A summary of different tissue/sample types, nomenclature, and descriptions can be found in [Table 1](#tbl1){ref-type="table"}.

Culture Media, Growth Factors, and Small Molecules {#sec4.4}
--------------------------------------------------

Information for serum-free basal media, growth factors, and small molecules, and the in-house generation and isolation of human recombinant FGF10, including company information and catalog numbers, can be found in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

RNA-Seq and Bioinformatics Analysis {#sec4.5}
-----------------------------------

RNA-seq and alignment was carried out as published previously ([@bib18]). Data analysis was performed using the R statistical programming language (<http://www.R-project.org/>) as described previously ([@bib10], [@bib14], [@bib38]). The complete sequence alignment, expression analysis, and all corresponding scripts can be found at <https://github.com/hilldr/Miller_Lung_Organoids_2017>.

Naphthaline Injury {#sec4.6}
------------------

Naphthaline (Sigma no. 147141) was dissolved in corn oil at a concentration of 40 mg/mL. Adult male NSG mice were chosen for these experiments because we observed improved recovery and survival following injury compared with female mice. Mice that were 8--10 weeks of age were given intraperitoneal injections at a dose of 300 mg/kg weight.

Intratracheal Injection of Fetal Progenitor Organoids and hPSC-Derived Bud Tip Organoid Cells into Immunocompromised Mouse Lungs {#sec4.7}
--------------------------------------------------------------------------------------------------------------------------------

### Generating Single Cells from Organoid Tissues {#sec4.7.1}

Two to three Matrigel droplets containing organoid tissues were removed from the culture plate and combined in a 1.5 mL Eppendorf tube with 1 mL of room temperature Accutase (Sigma no. A6964). The tube was laid on its side to prevent organoids from settling to the bottom. Tissue was pipetted up and down 15--20 times with a 1 mL tip every 5 min for a total of 20 min. Single cell status was determined by microscopic observation using a hemocytometer. Cells were diluted to a concentration of 500,000--600,000 cells per 0.03 mL in sterile PBS.

### Intratracheal Injection of Cells {#sec4.7.2}

Injection of cells into the mouse trachea was performed as described previously ([@bib1], [@bib3]). In brief, animals were anesthetized and intubated. Animals were given 500,000--600,000 single cells in 30--35 μL of sterile PBS through the intubation cannula.

RNA Extraction and qRT-PCR Analysis {#sec4.8}
-----------------------------------

These procedures were carried out as described previously ([@bib6], [@bib14]), and see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. A list of primer sequences used can be found in [Table S1](#mmc1){ref-type="supplementary-material"}.

Tissue Preparation, Immunohistochemistry, Electron Microscopy, and Imaging {#sec4.9}
--------------------------------------------------------------------------

These procedures were carried out as described previously ([@bib10], [@bib34], [@bib35]), and see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Quantification and Statistical Analysis {#sec4.10}
---------------------------------------

All plots and statistical analysis were done using Prism 6 software (GraphPad). For statistical analysis of qRT-PCR results, at least three biological replicates for each experimental group were analyzed and plotted with the SEM. If only two groups were being compared, a two-sided Student\'s t test was performed. In assessing the effect of length of culture with FGF7 on gene expression in mouse buds ([Figure S2](#mmc1){ref-type="supplementary-material"}G), a one-way, unpaired ANOVA was performed for each individual gene over time. The mean of each time point was compared with the mean of the expression level for that gene at day 0 of culture. If more than two groups were being compared within a single experiment, an unpaired one-way ANOVA was performed followed by Tukey\'s multiple comparison test to compare the mean of each group with the mean of every other group within the experiment. For all statistical tests, a significance value of 0.05 was used. For every analysis, the strength of p values is reported in the figures according the following: p \> 0.05, ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01, ^∗∗∗^p ≤ 0.001, ^∗∗∗∗^p ≤ 0.0001. Details of statistical tests can be found in the figure legends.
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Accession Numbers {#app1}
=================

All raw RNA-seq data files have been deposited in the EMBL-EBI ArrayExpress database (ArrayExpress: E-MTAB-6023). Adult human RNA-seq samples representing bulk sequencing of whole-lung homogenates were obtained from the EMBL-EBI ArrayExpress repository (ArrayExpress: E-MTAB-1733) ([@bib13]).
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